Gene therapies delivered major breakthroughs, including treatments that halve cholesterol levels in patients with inherited cardiovascular risk, advances for people living with thalassemia and highly ...

VectoryY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today the ...

NBIX heads into fourth-quarter earnings with Ingrezza sales strength, growing Crenessity revenues and rising focus on late-stage pipeline updates.

The Netherlands' MedTech startups lead healthcare innovation through AI diagnostics, medical devices, and digital health ...

Neurodegenerative diseases (NDs) are among the most urgent global health challenges, affecting millions worldwide and placing a growing burden on healthcare ...

Huntington’s disease (HD) is a fatal brain disorder caused by a defect in the huntingtin (HTT) gene, which produces an extra-long protein. This defect causes the HTT protein to form harmful clumps, or ...

Researchers have elucidated key steps in the ubiquitin tagging of the mutated huntingtin protein, providing hope for future ...

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the leading cause of liver disease worldwide, affecting one in three people.1,2 The inflammatory form of MASLD, namely ...

Detailed price information for Wave Life Sci Ord Sh (WVE-Q) from The Globe and Mail including charting and trades.

HRT can also be a concern after treatment. If you’ve been treated for HR+ breast cancer, “There is always some small risk ...

The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of ...